Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company using protein dynamics to develop precision cancer therapies is acquiring a drug discovery… https://t.co/AzEb3ERy5f
    about 6 hours ago
  • New post on Science and Enterprise: AI Drug Discovery Company Acquired in $270M Deal https://t.co/GhPSuGMAHO #Science #Business
    about 6 hours ago
  • Drug maker Eli Lilly and Co. asked the Food and Drug Administration to revoke its authorization for bamlanivimab al… https://t.co/xtrdcKMDgx
    about 12 hours ago
  • New post on Science and Enterprise: Lilly Asks FDA to Revoke Covid-19 Therapy Clearance https://t.co/FNA6Qlklwy #Science #Business
    about 12 hours ago
  • Vaccine developer Novavax is taking part in a clinical trial testing effects of different Covid-19 vaccines in firs… https://t.co/AMeVYLYh30
    about 1 day ago

Please share Science & Enterprise

Cell-Based Fish Company Gains $8.25M in Seed Funds

Bluu Bioscience founders

The start-up enterprise Bluu Biosciences is underway creating seafood products from fish stem cells, and raising $US 8.25 million in seed funds. . . . → Read More: Cell-Based Fish Company Gains $8.25M in Seed Funds

Venture Fund to Support Seed-Stage Biotechs

KdT Ventures management

A venture capital company raised $50 million to invest in new businesses developing innovative products and services at the junction of biology and engineering. . . . → Read More: Venture Fund to Support Seed-Stage Biotechs

Precision Cancer Immunotherapy Biotech Underway

T-cells and cancer cells

A new company is beginning work on a safer form of cancer immunotherapy that avoids toxic off-target effects, and raising $55 million in venture funds. . . . → Read More: Precision Cancer Immunotherapy Biotech Underway

Infographic – Stanford, MIT Lead Start-Up Alma Maters

Chart: start-up founder universities

The founders of start-up tech companies in the U.S. raising $1 million or more since 1 Jan. 2020 come from mainly top research institutions. . . . → Read More: Infographic – Stanford, MIT Lead Start-Up Alma Maters

Vaccine Spin-Off Raises $168 Million in New Funds

Syringes

A developer of vaccines, including a leading Covid-19 vaccine, and cancer immunotherapies, is raising $168 million in its second venture round. . . . → Read More: Vaccine Spin-Off Raises $168 Million in New Funds

Venture Investor to Back Underserved Tech Entrepreneurs

Smartphones in business meeting

An investment company is offering training and seed funds to women technology entrepreneurs, and those in LGBTQ, racial, and ethnic minority communities. . . . → Read More: Venture Investor to Back Underserved Tech Entrepreneurs

DNA Storage Company Gains $24M in New Funds

DNA analysis graphic

A maker of high-density chip devices storing data with nucleic acids similar to DNA is raising $24 million in its second venture financing round. . . . → Read More: DNA Storage Company Gains $24M in New Funds

Molecular Diagnostics Company Acquired in $1.8B Deal

Investment graphic

GenMark Diagnostics, a developer of diagnostics systems using genomic analysis, was acquired by drug maker Roche in a deal valued at $1.8 billion. . . . → Read More: Molecular Diagnostics Company Acquired in $1.8B Deal

Biotech Manufacturer Gains $525M in New Funds

BaseCamp lab

A company providing specialized lab and manufacturing services for cell and gene therapy developers is raising $525 million in its third venture funding round. . . . → Read More: Biotech Manufacturer Gains $525M in New Funds

Smart Walking System Wins Multiple Sclerosis Challenge

Neurons

A company developing systems to assist with walking is the winner of a competition for innovations to help people with multiple sclerosis. . . . → Read More: Smart Walking System Wins Multiple Sclerosis Challenge